Stereospecific reduction of virginiamycin M1 as the virginiamycin resistance pathway in Streptomyces virginiae.
In a cell extract of Streptomyces virginiae, virginiamycin M1 was inactivated in the presence of NADPH, while virginiamycin S remained intact. The inactivated product of virginiamycin M1 was isolated, and structure analysis revealed that the inactivation involves reduction of a C-16 carbonyl group leading to the formation of 16-dihydrovirginiamycin M1. Acetonide and benzylidene acetal derivatives were synthesized from the two hydroxyl groups on C-14 and C-16, and the C-16 stereochemistry was determined by 13C nuclear magnetic resonance spectroscopy. Two methyl groups of the acetonide derivative gave 13C signals of 20.1 and 30.1 ppm, indicating that the relative stereochemistry of the C-14 and C-16 hydroxy groups is syn. Furthermore, irradiation of the benzylidene methine proton gave clear nuclear Overhauser effect enhancement of the C-14 or C-16 methine protons, indicating that H-14 and H-16 were in an axial configuration. From the (14S) absolute configuration of natural virginiamycin M1 and the syn relative configuration for the C-14 and C-16 hydroxyl groups of the inactivated product, the C-16 absolute configuration of the inactivated product was thus identified as R.
Lee
C K
CK
Department of Biotechnology, Osaka University, Japan.
Minami
M
M
Sakuda
S
S
Nihira
T
T
Yamada
Y
Y
D000900:Anti-Bacterial Agents / Q000378:metabolism* / Q000494:pharmacology*; D002851:Chromatography, High Pressure Liquid; D004352:Drug Resistance, Microbial; D009682:Magnetic Resonance Spectroscopy; D008826:Microbial Sensitivity Tests; D010084:Oxidation-Reduction; D013055:Spectrophotometry, Infrared; D013237:Stereoisomerism; D013302:Streptomyces / Q000187:drug effects* / Q000378:metabolism*; D014769:Virginiamycin / Q000378:metabolism* / Q000494:pharmacology*
D000900:Anti-Bacterial Agents; D014769:Virginiamycin